FYN–TRAF3IP2 induces NF-κB signaling-driven peripheral T-cell lymphoma-Reference-Cited by-同舟云学术

FYN–TRAF3IP2 induces NF-κB signaling-driven peripheral T-cell lymphoma

Published:2021-01 Issue:1 Volume:2 Page:98-113
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Moon Christine S.^ORCID,Reglero Clara,Cortes Jose R.,Quinn S. Aidan,Alvarez Silvia,Zhao Junfei,Lin Wen-Hsuan W.^ORCID,Cooke Anisha J.,Abate Francesco,Soderquist Craig R.,Fiñana Claudia^ORCID,Inghirami Giorgio^ORCID,Campo Elias,Bhagat Govind^ORCID,Rabadan Raul^ORCID,Palomero Teresa^ORCID,Ferrando Adolfo A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s43018-020-00161-w.pdf

Reference66 articles.

1. Vose, J., Armitage, J. & Weisenburger, D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26, 4124–4130 (2008).

2. Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25–38 (2011).

3. Palomero, T. et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat. Genet. 46, 166–170 (2014).

4. Sakata-Yanagimoto, M. et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 171–175 (2014).

5. Cairns, R. A. et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119, 1901–1903 (2012).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‐cell transcriptome sequencing reveals SPP1‐CD44‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC;Journal of Cellular and Molecular Medicine;2024-07

2. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

3. Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches;The Innovation Medicine;2024

4. Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches;The Innovation Medicine;2024

5. Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions;Haematologica;2023-11-21